CXCR3 deficiency prolongs Th1-type contact hypersensitivity

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6059-6070

  Suga, Hiraku ^a   Sugaya, Makoto ^a   Miyagaki, Tomomitsu ^a   Ohmatsu, Hanako ^a   Okochi, Hitoshi ^b   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; CROSS PRESENTATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; IRRITANTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 84879104141     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201606     Document Type: Article

References (55)

1. Kaplan, D. H., A. Kissenpfennig, and B. E. Clausen. 2008. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38: 2369-2376.
2. Saint-Mezard, P., F. Berard, B. Dubois, D. Kaiserlian, and J. F. Nicolas. 2004. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur. J. Dermatol. 14: 131-138. (Pubitemid 38738449)
3. Takeshita, K., T. Yamasaki, S. Akira, F. Gantner, and K. B. Bacon. 2004. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int. Immunol. 16: 685-695. (Pubitemid 38628416)
4. Tang, A., T. A. Judge, B. J. Nickoloff, and L. A. Turka. 1996. Suppression of murine allergic contact dermatitis by CTLA4Ig: tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157: 117-125. (Pubitemid 26190538)
5. Dearman, R. J., and I. Kimber. 2000. Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology 101: 442-451. (Pubitemid 32001458)
6. Takeshita, K., T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon. 2004. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int. Immunol. 16: 947-959. (Pubitemid 38960873)
7. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161: 72-87. (Pubitemid 15169721)
8. Chai, J. G., S. A. Xue, D. Coe, C. Addey, I. Bartok, D. Scott, E. Simpson, H. J. Stauss, S. Hori, S. Sakaguchi, and J. Dyson. 2005. Regulatory T cells, derived from naive CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 79: 1310-1316. (Pubitemid 40734792)
9. Taylor, P. A., C. J. Lees, and B. R. Blazar. 2002. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493-3499. (Pubitemid 34534513)
10. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796. (Pubitemid 32224903)
11. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
12. Green, E. A., L. Gorelik, C. M. McGregor, E. H. Tran, and R. A. Flavell. 2003. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100: 10878-10883. (Pubitemid 37140121)
13. Fahlén, L., S. Read, L. Gorelik, S. D. Hurst, R. L. Coffman, R. A. Flavell, and F. Powrie. 2005. T cells that cannot respond to TGF-beta escape control by CD4 (+)CD25(+) regulatory T cells. J. Exp. Med. 201: 737-746. (Pubitemid 40395119)
14. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
15. Miyara, M., Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, C. Parizot, C. Taflin, T. Heike, D. Valeyre, et al. 2009. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
16. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631.
17. Ito, T., S. Hanabuchi, Y. H. Wang, W. R. Park, K. Arima, L. Bover, F. X. Qin, M. Gilliet, and Y. J. Liu. 2008. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
18. Huehn, J., K. Siegmund, J. C. Lehmann, C. Siewert, U. Haubold, M. Feuerer, G. F. Debes, J. Lauber, O. Frey, G. K. Przybylski, et al. 2004. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199: 303-313. (Pubitemid 38252043)
19. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
20. Zheng, Y., A. Chaudhry, A. Kas, P. deRoos, J. M. Kim, T. T. Chu, L. Corcoran, P. Treuting, U. Klein, and A. Y. Rudensky. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
21. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568. (Pubitemid 28207705)
22. Lacotte, S., S. Brun, S. Muller, and H. Dumortier. 2009. CXCR3, inflammation, and autoimmune diseases. Ann. N. Y. Acad. Sci. 1173: 310-317.
23. Melter, M., A. Exeni, M. E. Reinders, J. C. Fang, G. McMahon, P. Ganz, W. W. Hancock, and D. M. Briscoe. 2001. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104: 2558-2564. (Pubitemid 33104793)
24. Liu, L., M. K. Callahan, D. Huang, and R. M. Ransohoff. 2005. Chemokine receptor CXCR3: an unexpected enigma. Curr. Top. Dev. Biol. 68: 149-181. (Pubitemid 43588858)
25. Panzer, U., R. R. Reinking, O. M. Steinmetz, G. Zahner, U. Sudbeck, S. Fehr, B. Pfalzer, A. Schneider, F. Thaiss, M. Mack, et al. 2004. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation 78: 1341-1350. (Pubitemid 39507974)
26. Panzer, U., O. M. Steinmetz, H. J. Paust, C. Meyer-Schwesinger, A. Peters, J. E. Turner, G. Zahner, F. Heymann, C. Kurts, H. Hopfer, et al. 2007. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J. Am. Soc. Nephrol. 18: 2071-2084. (Pubitemid 47041073)
27. Erhardt, A., C. Wegscheid, B. Claass, A. Carambia, J. Herkel, H. W. Mittrücker, U. Panzer, and G. Tiegs. 2011. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. J. Immunol. 186: 5284-5293.
28. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
29. Watanabe, R., M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki. 2007. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am. J. Pathol. 171: 560-570. (Pubitemid 47344688)
30. Sugaya, M., Y. Kuwano, H. Suga, T. Miyagaki, H. Ohmatsu, T. Kadono, H. Okochi, A. Blauvelt, K. Tamaki, and S. Sato. 2012. Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J. Invest. Dermatol. 132: 667-676.
31. Szabo, S. K., C. Hammerberg, Y. Yoshida, Z. Bata-Csorgo, and K. D. Cooper. 1998. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J. Invest. Dermatol. 111: 1072-1078. (Pubitemid 29115177)
32. He, D., L. Wu, H. K. Kim, H. Li, C. A. Elmets, and H. Xu. 2006. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177: 6852-6858. (Pubitemid 44715050)
33. Kish, D. D., X. Li, and R. L. Fairchild. 2009. CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J. Immunol. 182: 5949-5959.
34. Clark, R. A., B. Chong, N. Mirchandani, N. K. Brinster, K. Yamanaka, R. K. Dowgiert, and T. S. Kupper. 2006. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176: 4431-4439. (Pubitemid 44264423)
35. Homey, B., W. Wang, H. Soto, M. E. Buchanan, A. Wiesenborn, D. Catron, A. Müller, T. K. McClanahan, M. C. Dieu-Nosjean, R. Orozco, et al. 2000. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J. Immunol. 164: 3465-3470. (Pubitemid 30169794)
36. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780. (Pubitemid 29399540)
37. Hasegawa, H., A. Inoue, M. Kohno, J. Lei, T. Miyazaki, O. Yoshie, M. Nose, and M. Yasukawa. 2008. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther. 15: 171-182. (Pubitemid 351175219)
38. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204. (Pubitemid 34256349)
39. Müller, M., S. L. Carter, M. J. Hofer, P. Manders, D. R. Getts, M. T. Getts, A. Dreykluft, B. Lu, C. Gerard, N. J. King, and I. L. Campbell. 2007. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 179: 2774-2786.
40. Tokuriki, A., N. Seo, T. Ito, M. Kumakiri, M. Takigawa, and Y. Tokura. 2002. Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-gamma-producing CD8(+) T cells in IP-10 expression. J. Dermatol. Sci. 28: 234-241. (Pubitemid 34242658)
41. Mori, T., K. Kabashima, R. Yoshiki, K. Sugita, N. Shiraishi, A. Onoue, E. Kuroda, M. Kobayashi, U. Yamashita, and Y. Tokura. 2008. Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated Langerhans cell Th2 chemokines. J. Invest. Dermatol. 128: 1719-1727. (Pubitemid 351847394)
42. Reiss, Y., A. E. Proudfoot, C. A. Power, J. J. Campbell, and E. C. Butcher. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194: 1541-1547. (Pubitemid 33081528)
43. Homey, B., H. Alenius, A. Müller, H. Soto, E. P. Bowman, W. Yuan, L. McEvoy, A. I. Lauerma, T. Assmann, E. Bünemann, et al. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8: 157-165. (Pubitemid 34155127)
44. Lehtimäki, S., S. Tillander, A. Puustinen, S. Matikainen, T. Nyman, N. Fyhrquist, T. Savinko, M. L. Majuri, H. Wolff, H. Alenius, and A. Lauerma. 2010. Absence of CCR4 exacerbates skin inflammation in an oxazolone-induced contact hypersensitivity model. J. Invest. Dermatol. 130: 2743-2751.
45. Hoerning, A., K. Koss, D. Datta, L. Boneschansker, C. N. Jones, I. Y. Wong, D. Irimia, K. Calzadilla, F. Benitez, P. F. Hoyer, et al. 2011. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur. J. Immunol. 41: 2291-2302.
46. Groom, J. R., and A. D. Luster. 2011. CXCR3 in T cell function. Exp. Cell Res. 317: 620-631.
47. Sawitzki, B., C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood. 2005. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201: 1925-1935. (Pubitemid 41002929)
48. Daniel, V., C. Naujokat, M. Sadeghi, R. Weimer, F. Renner, S. Yildiz, and G. Opelz. 2008. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl. Int. 21: 646-660. (Pubitemid 351852764)
49. Bettelli, E., M. Dastrange, and M. Oukka. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102: 5138-5143.
50. Turner, J. E., H. J. Paust, O. M. Steinmetz, A. Peters, J. H. Riedel, A. Erhardt, C. Wegscheid, J. Velden, S. Fehr, H. W. Mittrücker, et al. 2010. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 21: 974-985.
51. Ajuebor, M. N., J. A. Carey, and M. G. Swain. 2006. CCR5 in T cell-mediated liver diseases: what's going on? J. Immunol. 177: 2039-2045. (Pubitemid 44200959)
52. Erhardt, A., and G. Tiegs. 2010. Tolerance induction in response to liver inflammation. Dig. Dis. 28: 86-92.
53. Kim, C. H. 2006. Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system. Exp. Hematol. 34: 1033-1040. (Pubitemid 44080379)
54. Chaudhry, A., D. Rudra, P. Treuting, R. M. Samstein, Y. Liang, A. Kas, and A. Y. Rudensky. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326: 986-991.
55. Kish, D. D., A. V. Gorbachev, and R. L. Fairchild. 2005. CD8+ T cells produce IL-2, which is required for CD(4+)CD25+ T cell regulation of effector CD8+ T cell development for contact hypersensitivity responses. J. Leukoc. Biol. 78: 725-735. (Pubitemid 41292095)